MLchartDataset catalogue

Camptosar

Term · Oncology and biomedicine · MLC-T-ONC-001356

A drug used alone or with other drugs to treat colorectal cancer that has spread to other parts of the body. It is used in patients whose cancer has not already been treated or whose cancer has recurred (come back) or has gotten worse after treatment with anticancer drugs that included fluorouracil. It is also being studied in the treatment of other types of cancer. Camptosar blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called CPT 11 and irinotecan hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-001356
FieldOncology and biomedicine
SynonymsCPT 11; irinotecan hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001356",
  "term": "Camptosar",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat colorectal cancer that has spread to other parts of the body. It is used in patients whose cancer has not already been treated or whose cancer has recurred (come back) or has gotten worse after treatment with anticancer drugs that included fluorouracil. It is also being studied in the treatment of other types of cancer. Camptosar blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called CPT 11 and irinotecan hydrochloride.",
  "synonyms": [
    "CPT 11",
    "irinotecan hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/camptosar/"
}

Record 4,056 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.